TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9866379

Group type: EXPERIMENTAL
Intervention: Mass screening for prostatic cancer (submitted to screening 1 year ago)
Number of subjects: 186

Group type: COMPARATOR
Intervention: No mass screening (not submitted for 3 years)
Number of subjects: 186
Study: 8562236

Group type: COMPARATOR
Intervention: Intermittent hypothermic cardioplegia
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continuous normothermic blood cardioplegia
Number of subjects: 24
Study: 2679829

Group type: EXPERIMENTAL
Intervention: Ossein-hydroxyapatite compound (OHC) treatment providing 1.6 g calcium, 0.74 g phosphorus, and 1.94 g noncollagen peptides per day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ossein-hydroxyapatite compound (OHC) treatment
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Estrogen/progesterone substitution in poor responders
Number of subjects: 48
Study: 4157353

Group type: EXPERIMENTAL
Intervention: Cephalexin for 10 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Phenoxymethyl penicillin for 10 days
Number of subjects: 128

Group type: COMPARATOR
Intervention: Benzathine penicillin (single injection)
Number of subjects: 128
Study: 30605396

Group type: EXPERIMENTAL
Intervention: Heat therapy (HT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Thermoneutral intervention (Control)
Number of subjects: 11
Study: 28293099

Group type: EXPERIMENTAL
Intervention: Colorimetric assessment of vaginal pH
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Nugent score > 7 (gold standard)
Number of subjects: 1216
Study: 25944606

Group type: EXPERIMENTAL
Intervention: Measurement of gestational sac volume in physiological pregnancies
Number of subjects: 413

Group type: COMPARATOR
Intervention: Measurement of gestational sac volume in missed abortion
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Correlation analysis of gestational sac size and pregnancy development
Number of subjects: 413
Study: 23580109

Group type: EXPERIMENTAL
Intervention: Pirfenidone single doses (200, 400, and 600 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pirfenidone multiple doses (400 mg, 3 times daily)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 5‐carboxy‐pirfenidone (metabolite)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urinary excretion of pirfenidone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urinary excretion of unchanged pirfenidone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Safety assessment
Number of subjects: 20
Study: 21317789

Group type: EXPERIMENTAL
Intervention: CEMHaVi program (exercise and health education)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal care of a physician in pediatrics (control)
Number of subjects: 74
Study: 19762765

Group type: COMPARATOR
Intervention: IVRA lidocaine plus IV saline (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IVRA lidocaine and paracetamol (300 mg) admixture plus IV saline (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: IVRA lidocaine plus IV paracetamol (300 mg) (Group 3)
Number of subjects: 60
Study: 17823676

Group type: EXPERIMENTAL
Intervention: Resin composite core with prefabricated posts
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amalgam core with prefabricated posts
Number of subjects: 45

Group type: COMPARATOR
Intervention: Glass-ionomer core with custom post
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Composite core with prefabricated posts
Number of subjects: 45
Study: 15072715

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Acetazolamide 125 mg twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 14665887

Group type: EXPERIMENTAL
Intervention: 1 mmol/l CAP diluted in glucidic solvent
Number of subjects: 39

Group type: COMPARATOR
Intervention: 100 nMol/l RTX diluted in 10% ethanol
Number of subjects: 39
Study: 11197264

Group type: EXPERIMENTAL
Intervention: Mesalamine therapy (4 g daily for 18 months)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Mesalamine therapy (in subgroup with isolated small bowel Crohn's disease)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Placebo (in subgroup with isolated small bowel Crohn's disease)
Number of subjects: 318
Study: 9250794

Group type: EXPERIMENTAL
Intervention: Somatostatin receptor scintigraphy (110 or 220 MBq of 111In‐pentetreotide)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Somatostatin receptor scintigraphy
Number of subjects: 35
Study: 8048662

Group type: EXPERIMENTAL
Intervention: Venodilators (sustonit-mitte)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Mixed vasodilators and arteriolodilators (prazosin, cordafen)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Venodilators
Number of subjects: 92
Study: 3469935

Group type: EXPERIMENTAL
Intervention: Cefmenoxime plus amikacin
Number of subjects: 101

Group type: COMPARATOR
Intervention: Piperacillin plus amikacin
Number of subjects: 101
Study: 28527646

Group type: EXPERIMENTAL
Intervention: Tight glucose control (4-6 mmol/l, IV insulin, n = 9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard glucose control (6-10 mmol/l, SC insulin, n = 9)
Number of subjects: 18
Study: 26179771

Group type: EXPERIMENTAL
Intervention: 20 µg teriparatide (PTH 1-34 (Forteo)) for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 40
Study: 25364081

Group type: EXPERIMENTAL
Intervention: CPAP and telemedicine (n = 54)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard care CPAP (n = 53)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 107
Study: 23936985

Group type: EXPERIMENTAL
Intervention: Dairy product-restricted diets (intervention group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Liberal diets (control group)
Number of subjects: 62
Study: 20945990

Group type: EXPERIMENTAL
Intervention: CinnoVex™
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Avonex®
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rebif®
Number of subjects: 70

Group type: COMPARATOR
Intervention: Betaferon®
Number of subjects: 70

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 70
Study: 19140845

Group type: EXPERIMENTAL
Intervention: Epoetin-beta (3000 IU)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Epoetin-beta (6000 IU)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (2 or 3 times per week administration of epoetin-beta)
Number of subjects: 112
Study: 16775089

Group type: EXPERIMENTAL
Intervention: Intracoronary autologous bone marrow cell transplantation (BMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bone marrow supernatant (control)
Number of subjects: 20
Study: 14687422

Group type: EXPERIMENTAL
Intervention: Ultrasound Tissue Doppler Imaging (TDI) of Arterial Wall Motion (AWM)
Number of subjects: 126
Study: 10377609

Group type: EXPERIMENTAL
Intervention: blackcurrant/calcium concentrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: blackcurrant/calcium drink
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: apple & blackcurrant concentrate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: orange concentrate
Number of subjects: 15

Group type: COMPARATOR
Intervention: water
Number of subjects: 15
Study: 8878339

Group type: EXPERIMENTAL
Intervention: Bright light treatment administered when well
Number of subjects: 12

Group type: COMPARATOR
Intervention: No bright light treatment until first symptoms of depression
Number of subjects: 12
Study: 1300312

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg, two tablets a day for 90 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6387952

Group type: EXPERIMENTAL
Intervention: Chymopapain (chemonucleolysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical management techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative management techniques
Number of subjects: 0
Study: 31722024

Group type: EXPERIMENTAL
Intervention: Intranasal naloxone hydrochloride 800 μg per 1 mL
Number of subjects: 197

Group type: COMPARATOR
Intervention: Intramuscular naloxone hydrochloride 800 μg per 1 mL
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Intranasal naloxone
Number of subjects: 197

Group type: COMPARATOR
Intervention: Intramuscular naloxone
Number of subjects: 197
Study: 28917592

Group type: EXPERIMENTAL
Intervention: Prefrontal tDCS (n=16); anode-left-prefrontal/cathode-right-sensory
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Motor tDCS (n=14); anode-motor/cathode-right prefrontal
Number of subjects: 58

Group type: COMPARATOR
Intervention: Active-Control tDCS (n=15); anode-left-temporal-occipital junction/cathode-medial-anterior-premotor-area
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham tDCS (n=13); 0 mA-current stimulation
Number of subjects: 58
Study: 26372368

Group type: COMPARATOR
Intervention: Gender dialogue groups in addition to group savings for child brides
Number of subjects: 682

Group type: COMPARATOR
Intervention: Combined intervention arm for nonchild brides
Number of subjects: 682
Study: 22554394

Group type: EXPERIMENTAL
Intervention: On-site education with an academic detailer
Number of subjects: 64

Group type: COMPARATOR
Intervention: Quitline materials delivered by mail
Number of subjects: 64
Study: 21926651

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (IG1) - attended the program and received a take-home pack
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (IG2) - received a take-home pack only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison group (CG) - received no intervention
Number of subjects: 60
Study: 19461552

Group type: EXPERIMENTAL
Intervention: TENS (45-min treatment, sensory, biphasic square wave stimulation, 150-mus phase duration, 150 pps)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Focal knee joint cooling (20-min treatment with two 1.5-L ice bags)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 33
Study: 17717439

Group type: EXPERIMENTAL
Intervention: Standard burn care plus oxandrolone (0.1 mg/kg body weight q.12 hours p.o, n = 45)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Standard burn care (control, n = 190)
Number of subjects: 235
Study: 15072733

Group type: EXPERIMENTAL
Intervention: Reduced use of cosmetics with special instructions on skin care
Number of subjects: 48
Study: 11870016

Group type: EXPERIMENTAL
Intervention: E-EPA (ethyl ester of eicosapentaenoic acid)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9670348

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 231

Group type: COMPARATOR
Intervention: Weighted-Play-the-Winner (WPW) design
Number of subjects: 231

Group type: COMPARATOR
Intervention: WPWI (Weighted-Play-the-Winner with inheritance)
Number of subjects: 231
Study: 7827669

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 63

Group type: COMPARATOR
Intervention: Nonasthmatic children (control group)
Number of subjects: 63
Study: 2365876

Group type: EXPERIMENTAL
Intervention: Philips TL12 fluorescent lamps (UVB/UVC ratio 8.7)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wolff Helarium lamps (UVB/UVC ratio greater than 1300)
Number of subjects: 0
Study: 742355

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Melfalan (Group A)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with adriamycin and Melfalan (Group B)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Melfalan (Group A) among premenopausal patients
Number of subjects: 79

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with adriamycin and Melfalan (Group B) among premenopausal patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with Melfalan (Group A) among postmenopausal patients
Number of subjects: 79

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with adriamycin and Melfalan (Group B) among postmenopausal patients
Number of subjects: 79
Study: 6981171

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 320 mg of TMP and 1,600 mg of SMZ daily for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chloramphenicol 2 g daily for 14 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ)
Number of subjects: 60
Study: 29113530

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pentoxifylline
Number of subjects: 30
Study: 27665852

Group type: EXPERIMENTAL
Intervention: Biolimus A9-eluting stent (BES)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 81
Study: 24797396

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including emails, posters, campus events, factsheets/booklets, and mental health first aid training courses.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 22814045

Group type: EXPERIMENTAL
Intervention: Metal posterior sub-Tenon cannula
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Flexible posterior sub-Tenon cannula
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Flexible medium sub-Tenon cannula
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 159
Study: 20400416

Group type: EXPERIMENTAL
Intervention: Topical alkane vapocoolant spray
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 62
Study: 17592908

Group type: EXPERIMENTAL
Intervention: Psychoeducational group therapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 48
Study: 15273528

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg b.i.d. (n = 198)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Naproxen 500 mg b.i.d. (n = 198)
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 397

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 397
Study: 11385200

Group type: EXPERIMENTAL
Intervention: Vitremer
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketac Molar
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: F‐2000
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pertac II
Number of subjects: 12
Study: 9342601

Group type: EXPERIMENTAL
Intervention: Lorazepam (1 mg bid)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8518523

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (6 mg/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cyclophosphamide (2.5 mg/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (children in complete remission and off therapy)
Number of subjects: 12
Study: 3688153

Group type: EXPERIMENTAL
Intervention: Cookie-decorating activity with altruistic purpose (cookies as a gift for preschool)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Cookie-decorating activity without altruistic purpose (no gift)
Number of subjects: 130
Study: 29759785

Group type: EXPERIMENTAL
Intervention: Robotic navigation (RN) ablation
Number of subjects: 258

Group type: COMPARATOR
Intervention: Manual ablation (MN)
Number of subjects: 258
Study: 25986222

Group type: EXPERIMENTAL
Intervention: Home-based adapted physical activity (APA) program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 44
Study: 24387685

Group type: EXPERIMENTAL
Intervention: Fixation then inflation (study group)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Inflation then fixation (control group)
Number of subjects: 184
Study: 21920963

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 172
Study: 20120663

Group type: EXPERIMENTAL
Intervention: Quadriceps Education Device (QED)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-QED
Number of subjects: 60
Study: 17943573

Group type: EXPERIMENTAL
Intervention: Intranasal ciclesonide 200 microg once daily
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: HFA‐BDP 320 microg twice daily during run-in period
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Dexamethasone 2 mg on last treatment day
Number of subjects: 150
Study: 16358992

Group type: EXPERIMENTAL
Intervention: Ambulatory obstetric and gynaecological services
Number of subjects: 635
Study: 11599064

Group type: EXPERIMENTAL
Intervention: Injection rate of 0.5 mL/second
Number of subjects: 37

Group type: COMPARATOR
Intervention: Injection rate of 1.5 mL/second
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Higher injection rates (0.5, 1.5, and 3.0 mL/second) in volunteers
Number of subjects: 37
Study: 9725493

Group type: EXPERIMENTAL
Intervention: Milnacipran (50 mg oral and intravenous doses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (6 subjects)
Number of subjects: 11
Study: 7528939

Group type: COMPARATOR
Intervention: Best sleeping position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nasal decongestant and position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nasal decongestant alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control night
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Position alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of nasal decongestant and position
Number of subjects: 20
Study: 3169044

Group type: EXPERIMENTAL
Intervention: Treatment (quinidine, disopyramide or mexiletine)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 96
Study: 31748596

Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS)
Number of subjects: 30
Study: 28272198

Group type: EXPERIMENTAL
Intervention: Practicing VR games during computer classes (including 15 minutes for practicing games in VR environment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computer classes (typical classes without VR games)
Number of subjects: 0
Study: 25338927

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 38

Group type: COMPARATOR
Intervention: saline
Number of subjects: 38
Study: 23512974

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (reduction of daily caloric intake by 400 kcal for 6 months)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Neuronal activity during a food specific memory task
Number of subjects: 33
Study: 21192145

Group type: EXPERIMENTAL
Intervention: Lamotrigine (40 patients) for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (40 patients) for 12 weeks
Number of subjects: 80
Study: 19553555

Group type: EXPERIMENTAL
Intervention: N. lactamica OMV vaccine
Number of subjects: 97

Group type: COMPARATOR
Intervention: Alhydrogel control
Number of subjects: 97
Study: 17785386

Group type: EXPERIMENTAL
Intervention: Dental amalgam
Number of subjects: 534

Group type: COMPARATOR
Intervention: Mercury-free resin-based composite
Number of subjects: 534
Study: 15119883

Group type: EXPERIMENTAL
Intervention: Bio‐Oss Collagen with a resorbable collagen barrier (Bio‐Gide)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Bio‐Oss Collagen without a resorbable collagen barrier
Number of subjects: 4
Study: 11350721

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Peer intervention
Number of subjects: 314
Study: 9797642

Group type: EXPERIMENTAL
Intervention: Sucrose polyester (SPE) 20-40 g daily (mean 26.8 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control fat
Number of subjects: 0
Study: 7657768

Group type: EXPERIMENTAL
Intervention: Endometriosis patients
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study: 2545640

Group type: EXPERIMENTAL
Intervention: Dietary fibre supplement of 7 g/day for 11 weeks (part I)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Dietary fibre supplement of 6 g/day for 16 weeks (part II)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Dietary fibre supplement of 6 g/day and an ad libitum diet for the rest of the period (part III)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Dietary fibre group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 97
Study: 1102879

Group type: EXPERIMENTAL
Intervention: Sustained-release 40 mg dicyclomine hydrochloride tablets (Merbentyl Dospan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 mg plain dicyclomine hydrochloride tablets (Merbentyl)
Number of subjects: 0
Study: 31775518

Group type: EXPERIMENTAL
Intervention: N‐acetylcysteine with a combination of nutraceuticals
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: N‐acetylcysteine alone
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study: 30973001

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intermittent renal replacement therapy (IRRT)
Number of subjects: 60
Study: 29025845

Group type: EXPERIMENTAL
Intervention: MPMRI-targeted biopsy
Number of subjects: 470

Group type: COMPARATOR
Intervention: TRUS biopsy
Number of subjects: 470
Study: 25758601

Group type: EXPERIMENTAL
Intervention: Indocyanine green angiography (ICGA)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Colour fundus photography
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ICGA
Number of subjects: 61
Study: 22939927

Group type: EXPERIMENTAL
Intervention: bovine lactoferrin (bLF)
Number of subjects: 555

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 555
Study: 21808295

Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19863177

Group type: EXPERIMENTAL
Intervention: (R-)CHOP
Number of subjects: 175

Group type: COMPARATOR
Intervention: B-ALL protocol
Number of subjects: 175